Catheter Precision
VTAK
13 hedge funds and large institutions have $1.5M invested in Catheter Precision in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
30% more funds holding
Funds holding: 10 → 13 (+3)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
23% less capital invested
Capital invested by funds: $1.95M → $1.5M (-$446K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$126K |
| 2 |
Bank of New York Mellon
New York
|
+$94.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$62.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.9K |
| 5 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$31.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$157K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$94.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$74K |
| 4 |
MA
MANA Advisors
New York
|
-$45K |
| 5 |
CFO
CVA Family Office
Denver,
Colorado
|
-$1K |
VTAK Hedge Fund Activity: Q3 2021 in Review
13 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2021, worth a combined $1.5M — down 23% from $1.95M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VTAK positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna Fundamental Investments, opening a new position worth an estimated $126K. The largest seller was Virtu Financial, cutting an estimated $157K.
- 13 institutional investors held Catheter Precision (VTAK) as of Q3 2021, up from 10 in Q2 2021.
- Funds reported $1.5M of Catheter Precision stock for Q3 2021, down 23% quarter-over-quarter.
- 5 funds opened new Catheter Precision positions in Q3 2021 and 2 closed out, a net change of +3 holders.
- The largest Catheter Precision buyer in Q3 2021 was Susquehanna Fundamental Investments, an estimated $126K added.
- The largest Catheter Precision seller in Q3 2021 was Virtu Financial, an estimated $157K sold.
Based on aggregated 13F filings for Q3 2021.